This is a preview of subscription content, log in via an institution to check access.
References
Carlsson MS, Denneberg T, Emanuelsson B-M, K»gedal B, Lindgren S (1990) Pharmacokinetics of intravenous 2-mercaptopropionylglycine in man. Eur J Clin Pharmacol 38: 499–503
Carlsson MS, Denneberg T, Emanuelsson B-M, K»gedal B, Lindgren S (1993) Pharmacokinetics of oral tiopronin. Eur J Clin Pharmacol 45: 79–84
Toshioka N, Mita I, Chiba T (1970) Absorption, distribution, metabolism and excretion of 35S-Thiola in rats. Proceedings of International Symposium on Thiola, Osaka Japan, Santen Pharmaceutical, pp 1–8
Hercelin B, Leroy P, Nicolas A, Gavriloff C, Chassard D et al. (1992) The pharmacokinetics of tiopronin and its principal metabolite (2-mercaptopropionic acid) after oral administration to healthy volunteers. Eur J Clin Pharmacol 43: 93–95
Hoppe A, Denneberg T, Emanuelsson B-M, K»gedal B, Lindgren S (1991) Pharmacokinetics and bioavailability of 2-mercaptopropionylglycine administered intravenously and orally in dogs. J Vet Pharmacol Ther 14: 374–384
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sjöström, P.A. Changes in clearance create pharmacokinetic pitfalls as illustrated by studies on tiopronin. Eur J Clin Pharmacol 46, 575 (1994). https://doi.org/10.1007/BF00196121
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00196121